In conclusion, the expression of CERS6-AS1 is upregulated in prostate cancer, and silencing CERS6-AS1 can inhibit the proliferation and migration of DU145 cells and promote cell apoptosis. This evidence concerns the gene CERS6 and prostate cancer.